This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gupta, M. K. Articles by Auchus, R. J. Search for Related Content PubMed PubMed Citation Articles by Gupta, M. K. Articles by Auchus, R. J.

Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase Deficiency

Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center (M.K.G., R.J.A.), Dallas, Texas 75390-8857; and Division of Pediatric Endocrinology, Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center (D.H.G.), Los Angeles, California 90048

Address all correspondence and requests for reprints to: Richard J. Auchus, M.D., Ph.D., Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8857. E-mail: richard.auchus{at}utsouthwestern.edu

Abstract

The cytochrome P450c17 enzyme system performs both the 17-hydroxylase and 17,20-lyase reactions in the human adrenal glands and gonads. This 17,20-lyase activity is required for the biosynthesis of dehydroepiandrosterone, the C₁₉ precursor of sex steroids. Considerable evidence supports the idea that the 17,20-lyase activity of this system is particularly sensitive to alterations in the interactions between P450c17 and its cofactor proteins P450-oxidoreductase and cytochrome b₅. We have described two patients with the clinical phenotype of isolated 17,20-lyase deficiency in whom single amino acid replacement mutations in the redox partner binding site of P450c17 (R347H and R358Q) selectively ablate 17,20-lyase activity while preserving most 17-hydroxylase activity. We have shown by computer modeling and detailed biochemical studies that mutations R347H and R358Q impair the interactions of P450c17 with P450-oxidoreductase and cytochrome b₅ (redox partners). Another mutation reported to cause isolated 17,20-lyase deficiency (F417C) does not map within the redox partner binding site, but might nonetheless alter the interaction of the mutant protein with redox partners. To study the interaction of the F417C mutation with P450 oxidoreductase and cytochrome b₅, we expressed the cDNA for this protein in yeast microsomes, a heterologous expression system in which the composition of redox partner proteins can be varied systematically. Although the full-length protein was expressed in quantities comparable to those of wild-type P450c17 in this system, the F417C mutation did not form a classical P450 difference spectrum and was devoid of both 17-hydroxylase and 17,20-lyase activities. To ensure that this result was not unique to the yeast expression system, we also expressed wild-type P450c17 and the F417C mutation in COS-7 cells, and we again found that the F417C mutation was expressed, but was not active. To conclusively demonstrate that a particular mutation in P450c17 causes isolated 17,20-lyase deficiency, accurate enzymatic studies of the mutant protein must reproducibly show activities consistent with the diagnosis. Mutations R347H and R358Q are the only two such mutations found in humans proven to cause isolated 17,20-lyase deficiency.

This article has been cited by other articles:

				J C. Pattison, D. H Abbott, W. Saltzman, A. J Conley, and I. M Bird Plasticity of the zona reticularis in the adult marmoset adrenal cortex: voyages of discovery in the New World J. Endocrinol., December 1, 2009; 203(3): 313 - 326. [Abstract] [Full Text] [PDF]

				L.-L. Wang, Y. Li, and S.-F. Zhou A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450 Drug Metab. Dispos., May 1, 2009; 37(5): 977 - 991. [Abstract] [Full Text] [PDF]

				S. Turan, A. Bereket, T. Guran, T. Akcay, M. Papari-Zareei, and R. J Auchus Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair Eur. J. Endocrinol., February 1, 2009; 160(2): 325 - 330. [Abstract] [Full Text] [PDF]

				E. Hershkovitz, R. Parvari, S. A. Wudy, M. F. Hartmann, L. G. Gomes, N. Loewental, and W. L. Miller Homozygous Mutation G539R in the Gene for P450 Oxidoreductase in a Family Previously Diagnosed as Having 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3584 - 3588. [Abstract] [Full Text] [PDF]

				S. Rosa, C. Duff, M. Meyer, M. Lang-Muritano, G. Balercia, M. Boscaro, A. Kemal Topaloglu, R. Mioni, F. Fallo, L. Zuliani, et al. P450c17 Deficiency: Clinical and Molecular Characterization of Six Patients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1000 - 1007. [Abstract] [Full Text] [PDF]

				B. Ergun-Longmire, R. Auchus, M. Papari-Zareei, S. Tansil, R. C. Wilson, and M. I. New Two Novel Mutations Found in a Patient with 17{alpha}-Hydroxylase Enzyme Deficiency J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4179 - 4182. [Abstract] [Full Text] [PDF]

				A. M. Brooke, N. F. Taylor, J. H. Shepherd, M. E. Gore, T. Ahmad, L. Lin, G. Rumsby, M. Papari-Zareei, R. J. Auchus, J. C. Achermann, et al. A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2428 - 2431. [Abstract] [Full Text] [PDF]

				W.-H. Yang and S. R Hammes Xenopus laevis CYP17 Regulates Androgen Biosynthesis Independent of the Cofactor Cytochrome b5 J. Biol. Chem., March 18, 2005; 280(11): 10196 - 10201. [Abstract] [Full Text] [PDF]

				N. M. Holmes, W. L. Miller, and L. S. Baskin Lack of Defects in Androgen Production in Children with Hypospadias J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2811 - 2816. [Abstract] [Full Text] [PDF]

				M. Costa-Santos, C. E. Kater, E. P. Dias, and R. J. Auchus Two Intronic Mutations Cause 17-Hydroxylase Deficiency by Disrupting Splice Acceptor Sites: Direct Demonstration of Aberrant Splicing and Absent Enzyme Activity by Expression of the Entire CYP17 Gene in HEK-293 Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 43 - 48. [Abstract] [Full Text] [PDF]

				M. Costa-Santos, C. E. Kater, and R. J. Auchus Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 49 - 60. [Abstract] [Full Text] [PDF]

				D. P. Sherbet, D. Tiosano, K. M. Kwist, Z. Hochberg, and R. J. Auchus CYP17 Mutation E305G Causes Isolated 17,20-Lyase Deficiency by Selectively Altering Substrate Binding J. Biol. Chem., December 5, 2003; 278(49): 48563 - 48569. [Abstract] [Full Text] [PDF]

				C. E. Fluck, W. L. Miller, and R. J. Auchus The 17, 20-Lyase Activity of Cytochrome P450c17 from Human Fetal Testis Favors the {Delta}5 Steroidogenic Pathway J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3762 - 3766. [Abstract] [Full Text] [PDF]

				E. L. T. van den Akker, J. W. Koper, A. L. M. Boehmer, A. P. N. Themmen, M. Verhoef-Post, M. A. Timmerman, B. J. Otten, S. L. S. Drop, and F. H. De Jong Differential Inhibition of 17{alpha}-Hydroxylase and 17,20-Lyase Activities by Three Novel Missense CYP17 Mutations Identified in Patients with P450c17 Deficiency J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5714 - 5721. [Abstract] [Full Text] [PDF]